Clinical trial
Effects of Two Intraoperative Arterial Oxygen Targets on Thiol-Disulfide Homeostasis and Ischemia-Modified Albumin in Coronary Artery Bypass Graft Surgery
NCT04627220 is registered in ClinicalTrials.gov with Bursa Yuksek Ihtisas Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Two Intraoperative Arterial Oxygen Targets on Thiol-Disulfide Homeostasis and Ischemia-Modified Albumin in Coronary Artery Bypass Graft Surgery
- Lead sponsor
- Bursa Yuksek Ihtisas Training and Research Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- November 1, 2020
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.